Vir Biotechnology Inc. (VIR)
10.43
0.00 (0.00%)
Upcoming Events
Latest Headlines
Vir Biotechnology to Host Conference Call for Third Quarter 2026 Financial Results
October 21, 2026 4:05 PM - BizWire
Form 8-K Vir Biotechnology, Inc. For: Oct 09
October 14, 2026 8:35 AM - SEC Filing
Vir Biotechnology and Gilead Sciences strike solid tumor drug deal
October 14, 2026 8:30 AM - StreetInsider
Vir Biotechnology Enters Multi-Program Collaboration and License Agreement with Gilead Sciences to Discover and Develop Novel PRO-XTEN® Dual-masked T-cell Engagers for Solid Tumors
October 14, 2026 8:30 AM - BizWire
Form 8-K Vir Biotechnology, Inc. For: Oct 08
October 8, 2026 8:39 AM - SEC Filing
FDA grants fast track status to Vir Biotechnology's prostate cancer drug
October 8, 2026 8:30 AM - StreetInsider
Vir Biotechnology Announces PSMA-targeted PRO-XTEN® Dual-masked T-cell Engager VIR-5500 Received FDA Fast Track Designation for the Treatment of Prostate Cancer
October 8, 2026 8:30 AM - BizWire
Vir Biotechnology (VIR) PT Raised to $22 at H.C. Wainwright
October 8, 2026 6:59 AM - StreetInsider
Vir Biotechnology names David Liu as chief medical officer
October 7, 2026 8:30 AM - StreetInsider
Vir Biotechnology Appoints David Liu as Chief Medical Officer
October 7, 2026 8:30 AM - BizWire
Form 3 Vir Biotechnology, Inc. For: Oct 05 Filed by: Sawaf Aziz
October 6, 2026 2:14 PM - SEC Filing
Vir Biotechnology to present hepatitis delta trial data at AASLD 2026
October 5, 2026 4:05 PM - StreetInsider
Vir Biotechnology to Present Expanded Phase 2 SOLSTICE Results for Elebsiran and Tobevibart in Hepatitis Delta at AASLD’s The Liver Meeting® 2026
October 5, 2026 4:05 PM - BizWire
Form 8-K Vir Biotechnology, Inc. For: Oct 01
October 1, 2026 8:34 AM - SEC Filing
Vir Biotechnology names Aziz Sawaf as CFO, effective Oct. 2026
October 1, 2026 8:30 AM - StreetInsider
Vir Biotechnology Appoints Aziz Sawaf as Chief Financial Officer
October 1, 2026 8:30 AM - BizWire
Raymond James Reiterates Strong Buy Rating on Vir Biotechnology (VIR)
September 28, 2026 2:03 PM - StreetInsider
Form 144 Vir Biotechnology, Inc. Filed by: O'Byrne Jason
September 17, 2026 10:15 AM - SEC Filing
Form 144 Vir Biotechnology, Inc. Filed by: O'Byrne Jason
August 25, 2026 11:07 AM - SEC Filing
Form 144 Vir Biotechnology, Inc. Filed by: O'Byrne Jason
August 24, 2026 5:11 PM - SEC Filing
Form 144 Vir Biotechnology, Inc. Filed by: O'Byrne Jason
August 21, 2026 3:24 PM - SEC Filing
Form 4 Vir Biotechnology, Inc. For: Aug 11 Filed by: MORE ROBERT J
August 12, 2026 2:31 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Vir Biotechnology (VIR)
August 10, 2026 6:44 AM - StreetInsider
Form SCHEDULE 13G Vir Biotechnology, Inc. Filed by: STATE STREET CORP
August 7, 2026 11:11 AM - SEC Filing
Vir Biotechnology (VIR) PT Lowered to $25 at Morgan Stanley
August 6, 2026 8:53 AM - StreetInsider
Vir Biotechnology Inc. (VIR) Tops Q2 EPS by 14c
August 5, 2026 5:38 PM - StreetInsider
Form 10-Q Vir Biotechnology, Inc. For: Jun 30
August 5, 2026 5:21 PM - SEC Filing
Form 8-K Vir Biotechnology, Inc. For: Aug 05
August 5, 2026 4:13 PM - SEC Filing
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2026 Financial Results
August 5, 2026 4:05 PM - BizWire
Form SCHEDULE 13G/A Vir Biotechnology, Inc. Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC
July 31, 2026 11:40 AM - SEC Filing
Full Article List
